OraSure Technologies | OSUR - Operating Profit

Stock Price
3.21
Daily Change
0.002 0.06%
Monthly
2.62%
Yearly
10.00%
Q2 Forecast
2.88

OraSure Technologies reported $-13.59M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Agilent USD 353M 90M Dec/2025
AngioDynamics USD -2.51M 5.41M Sep/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Bio-Rad Laboratories USD 63.9M 13.2M Sep/2025
Bruker USD 76.3M 7.6M Dec/2025
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Dentsply International USD 538M 26M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Illumina USD 256M 6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD -37.3M 667.5M Dec/2025
Repligen USD 19.97M 7.29M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
STAAR Surgical USD -10.93M 29.42M Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Trinity Biotech USD -509K 6.27M Sep/2025
Waters USD 270.52M 78.4M Dec/2025